BP
RETA

BBR Partners’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

BBR Partners’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12,666
Closed -$318K – 198
2022
Q3 		$318K Sell
12,666
-1,334
-10% -$33.5K 0.04% 133
2022
Q2 		$425K Hold
14,000
– – 0.05% 139
2022
Q1 		$459K Buy
+14,000
New +$459K 0.04% 140